New Zealand has tentatively cleared the COVID-19 vaccine that Pfizer (PFE) developed in partnership with BioNTech (BNTX) for 12-15-year olds, according to a …
Pfizer (PFE) has received approval from the U.S.
Pfizer (PFE) and BioNTech (BNTX) have agreed to supply 900 million doses of their COVID-19 vaccine, COMIRNATY, to the European Union. The agreement …
Pfizer (PFE) and BioNTech (BNTX) have received emergency use authorization (EUA) from the U.S.
Pfizer (PFE) posted better-than-expected 1Q results driven by strong business performance and contributions from BNT162b2, the Pfizer COVID-19 vaccine. Meanwhile, the pharmaceutical company …
Exelixis, an oncology-focused biotechnology company, entered into a clinical trial collaboration and supply agreement with Germany-based Merck KGaA, a science and technology company, …
Pfizer ramped up its 2021 full-year guidance as the US drug maker expects to generate $15 billion from the sale of its COVID-19 …
Shares of Pfizer (PFE) and BioNTech (BNTX) jumped over 12% and 27%, respectively, in pre-market trading on November 9 after the companies published …
Pfizer (PFE) has kicked off a Phase 2b study of vupanorsen (ANGPTL3) in statin-treated patients with elevated non-high-density lipoprotein cholesterol and triglycerides (TGs). …
Pfizer is planning to file an application to the U.S.
